Oxidative stress in brain: Neurodegenerative diseases and possible treatment (part III)

Progress in Nutrition

Volumn 8, Issue 4, 2006, Pages 241-256

  Passi, Siro ^a   Gianni, G ^b   Cocchi, M ^c  

^a AGE PLUS   (Italy)

^b AGE PLUS   (Italy)

^c Fondazione Villa Maria   (Italy)

Author keywords

Alzheimer's disease; Antioxidants; Blood barrier brain; Brain; Oxidative stress; Parkinson's disease

Indexed keywords

ALPHA TOCOPHEROL; AMINE OXIDASE (FLAVIN CONTAINING); AMINO ACID OXIDASE; ANTIOXIDANT; ARACHIDONIC ACID; ASCORBIC ACID; CALCIUM ION; DOCOSAHEXAENOIC ACID; DOPAMINE; GLUTAMIC ACID; HYDROGEN PEROXIDE; HYDROXYL RADICAL; INTERLEUKIN 1; INTERLEUKIN 6; IRON; LEVODOPA; NITRIC OXIDE; NORADRENALIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OXYGEN; OXYGENASE; PHOSPHOLIPID; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SEMIQUINONE; TUMOR NECROSIS FACTOR; TYROSINE; UNINDEXED DRUG; VITAMIN;

ADJUVANT THERAPY; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOOXIDATION; BRAIN LEVEL; BRAIN METABOLISM; CALCIUM TRANSPORT; CELL MEMBRANE; CLINICAL TRIAL; CYTOKINE RELEASE; DEGENERATIVE DISEASE; DRUG EFFICACY; DRUG MEGADOSE; ENERGY METABOLISM; FENTON REACTION; HUMAN; HYDROPHILICITY; KIDNEY; LIPID PEROXIDATION; LIPOPHILICITY; LIVER; MACROPHAGE; MACROPHAGE ACTIVATION; META ANALYSIS; MICROGLIA; NERVE CELL MEMBRANE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PANCREAS; PARKINSON DISEASE; PATHOGENESIS; STRUCTURE ACTIVITY RELATION; SYSTEMATIC REVIEW;

ANIMALIA;

EID: 33947728580     PISSN: 11298723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Bohr VA. Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic Biol Med 2002; 32: 804-12.
2. Ames BN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 2001; 475: 7-20.
3. Bielski BHJ, Cabelli DE. Superoxide and hydroxyl radical chemistry in aqueous solution. In: Active Oxygen in Chemistry, Foote CS, Valentine JS, Greenberg A, Liebman JF (eds.). Chapman and Hall, London, 1995: 66-104.
4. Halliwell B, Clement MV, Long LH. Hydrogen peroxide in the human body. FEBS Lett 2000; 486: 10-3.
5. Czapski G, Goldstein S. The role of the reactions of NO with superoxide and oxygen in biological systems: a kinetic approach. Free Radic Biol Med 1995; 19: 785-94.
6. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408: 239-47.
7. Murphy MP, Pacher MA, Scarlet JL, Martin SW. Peroxynitrite: A biologically significant oxidant. Gen Pharmacol 1998; 31: 179-86.
8. Nagy IZ. On the true role of oxygen free radicals in the living state, aging, and degenerative disorders. Ann NY Acad Sci 2001; 928: 187-99.
9. Usmar VM. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radic Biol Med 2000; 28: 1780-94.
10. Gutteridge JMC, Halliwell B. Antioxidants in nutrition, health, and disease. Oxford University Press, Oxford-New York-Tokio, 1994.
11. Atamna II, Cheumg I, Ame N. A method for detecting abasic sites in living cell: Age-dependent changes in base excision repair. Proc Natl Acad sci USA 2000; 97: 686-91.
12. Dizdaroglu M, Jaruga P, Birincioglu M, et al. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med 2002; 32: 1102-15.
13. Halliwell B, Gutteridge JMC. Free radicals in Biology and Medicine, third edition. Oxford University Press, Midsomer Norton, Avon England (and the refrences reported therein), 1999.
14. Beal FM. Oxidatively modified proteins in aging and disease. Free Radical Biol Med 2002; 32 (9): 797-803.
15. Szweda PA, Friguet B, Szweda L. Proteolysis, free radicals, and aging. Free Radical Biol Med 2002; 33 (1): 29-36.
16. Floyd RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 1999; 222: 236-45.
17. Prasad KN, Cole WC, Hovland AR, et al. Multiple antioxidants in the porevention and treatment of neurodegenerative disease: analysis of biologic rational. Curr Opin Neurol 1999; 12: 761-70.
18. Passi S, Cocchi M. Oxidative stress in brain. Progress in Nutrition 2006; 8 (2-3): 129-134, 183-189.
19. Youdim KA, Martin A, Joseph JA. Essential fatty acids and the brain: possible health implications. Int J Devl Neuroscience 2000; 18: 383-9.
20. Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease. Evidence supporting it. Annals Neurology 1992; 32: 804-12.
21. Yoitaka A, Hyttori N, Uchida K, et al. Immunohistochemical detection of 4-hydroxy-nonenal protein adducts in Parkinson's disease. Proc Nat Acad Sci USA 1996; 93: 2696-701.
22. Jenner P, Olnaw CW. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 1996; 47 (suppl): S161-S176.
23. Sian J, Dexter DT, Less AJ, et al. Alteration in glutathione levels in Parkinson's disease and other neurodegenerative disorders affective basal ganglia. Annals Neurology 1994; 36: 348-55.
24. Offen D, Gorodin S, Melamed E, et al. Dopamine melanin is actively phagocytized by PC12 cells and cerebellar granular cells: possible implications for the etiology of Parkinson's disease. Neurosc Letters 1999; 260: 101-4.
25. Chiueh CC, Rauhala P. Free radicals and MPTP-induced selective destruction of substantia nigra compacta neurons. Adv Pharmacol 1998; 42: 796-800.
26. Prasad KN, Cole WC, Hovland AR, et al. Multiple antioxidants in the prevention and treatment of neurodegenerative disease: analysis of biologic rationale. Current Opinion in Neurology 1999; 12: 761-70.
27. Koppal T, Drake J, Yatin S, et al. Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease. J Neurochem 1999; 72: 310-7.
28. Schipper HM, Cisse S, Stopa EG. Expression of heme oxygenase-1 in the senescent and Alzheimer's diseased brain. Ann Neurol 1995; 37: 758-68.
29. Schubert D, Behl C, Lesley R, et al. Amyloid peptides are toxic via a common oxidative mechanism. Proc NatlAcad Sci USA 1995; 92: 1989-93.
30. Coyle JT, Puttfarcken P. Oxidative stres, glutamate and neurodegenerative disorders. Science 1993; 262: 689-95.
31. Oteiza PI, Uchitel OD, Carrasquedo F, et al. Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. Neurochem Research 1997; 22 (4): 535-9.
32. Reese TS, Karnosky MJ. Fine structural localization of a blood brain barrier to exogenesis peroxidase. J Cell Biol 1967; 34: 207-17.
33. Rowland LP, Fink ME, Rubin LL. Cerebrospinal fluid: blood brai barrier, brai oedema and hydrocephalus. In Kandel ER, Schwartz JH, Jesse T, Eds, Principle of neural science. Elsevier, New York, 1992: 1050-60.
34. Gilgun-Sherki Y, Melamed E, Offen D. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 2001; 40: 959-75.
35. Friedman A, Kaufer D, Stener J, et al. Pyridostigmin brain penetration under stress enhances neuronal excitability and induced early immediate transcriptional response. Nature Medicine 1996; 2: 1382-5.
36. Blak L, King WA, Ikezaki K. Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene. J Neurosurgery 1990; 72: 912-6.
37. Gumerlock MK, Neuwelt EA. Therapeutic opening of the blood brain barrier in man. In "Bradbury MVB, Ed., Springer-Verlag, 1992; 525-42.
38. Rice M. J. Nerochem 1995; 64: 1790-5.
39. Vatassery GT. Vitamin E: neurochemistry and implication for Parkinson's disease. Ann NY Acad Sci 1992; 669: 92-110.
40. Pappert EJ, Tangney CC, Goetz CG, et al. Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose response study and correlations with plasma levels. Neurology 1996; 47: 1037-42.
41. Passi S, Maggio F, Ricci R, Cocchi M. Prolonged administration of ubiquinone (CoQ10) and ubiquinol diacetate to rats and guinea pigs. Progress in Nutrition 2003; 5 (1): 6-15.
42. Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002; 30 (6): 620-50.
43. Cadet JL, katz M, Jackson-Lewis V, et al. Vitamin E attenuates the tic effects of intrastiated injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral abd biochemical evidences. Brain Res 1989; 476: 10-5.
44. Perumal AS, Gopal VB, Tordzro WK, et al. Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging system in rat brain. Brai Res Bull 1992; 29: 699-701.
45. Martinovitz G, Melamed F, Cohen O, et al. Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP). Neurosc Letters 1986; 69: 192-7.
46. Perry TL, Yong VW, Hansen S, et al. α-tocopherol and β-carotene do not protect marmosets against the dopaminergic neutoxicity of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. J Neurol Sci 1987; 81: 321-31.
47. Gotz ME, Din A, Burger R, et al. Effects of lipoic acid on redox state of coenzyme in mice treated with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and diethyldithiocarbamate. Eur J Pharmacol 1994; 266: 291-300.
48. Packer L, Tritschler H, Wessel K. Neuroprotection by the metabolic antioxidants and α-lipoic acid. Free Rad Biol Med 1997; 22: 359-78.
49. Seaton TA, Jenner P, Marsden CD. Thioctic acid doen not restore glutathione levels of protection against the potentiation of 6-hydroxydopamine toxicity induced by glutathione depletion in rat brain. Neurological Transactions 1996; 103: 315-29.
50. Beal MF, Russel TM. Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases. Mol Aspect Med 1997; 18: S169-S179.
51. Jin BK, Shin DY, Jeong MY, et al. Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) toxicity in rats. Neurosc Letters 1998; 245: 61-4.
52. Stoll S, Hartmann II, Cohen SD, Muller WE. The potent free radical scavenger α-lipoic caid improves memory in aged mice: putative relationship to NMDA receptor deficits. Pharmacology, Biochemistry and Behavior 1993; 46: 799-805.
53. Greenmayere JT, Garcia-Osuna N, Greene JG. The endogenous cofactors, thioctic acid and dihydrolipoic acid, are neuroprotective against NMDA and malonic acid lesions of striatum. Neurosc Letters 1994; 171: 17-20.
54. Golbe LI, Farrel TLM, Davis PH. Case control study of early life dietary factors in Parkinson's disease. Arch Neurol 1988; 45: 1350-3.
55. Tanner C. Epidemiology of Parkinson's disease. Neurological Clinical 1992; 10: 317-27.
56. Fahn S. An open trial of high dosage antioxidants in early Parkinson's disease. Am J Clin Nutr 1991; 53: 3805-25.
57. DATAOP. Parkinson study group. Effects of tocopherol and deprenyl on the progression of disabilty of Parkinson's disease. New Engl J Med 1993; 328: 176-83.
58. De Rijk MC, Breteler MM, den Breeijen JII, et al. Dietary antioxidants and Parkinson's disease. The Rotterdam study. Arch Neurol 1997; 54 (6): 1762-5.
59. Logroscino G, Marker G, Cote L, et al. Dietary lipids and antioxidants in Parkinson's disease. Ann Neurol 1996; 39: 89-94.
60. Sechi G, Deeden MG, Bua G, et al. Reduced intravenous glutathione in the treatment of early Parkinson's disease. Progress Neuropsychopharmacology Biological Psychiatry 1966; 20: 1159-70.
61. Sano M, Erresto C, Thomas RG, et al. A controlled trial of segeline, alpha tocopherol or both as treatment for Alzheimer's disease. New Engl J Med 1997; 336: 1216-22.
62. Morris MC, Bechett LA, Scherr PA, et al. Vitamin E and vitamin C supplement use and risk of incident Alzheimer's disease. Alzheimer's Disease and associated Disorders 1998; 12 (3): 121-6.
63. Peyser CE, Folstein M, Chase GA, et al. Trial of α-tocopherol in Huntington's disease. Am J Psychiatry 1995; 152: 1771-5.
64. Schmidt R, Hayn M, Reihart B, et al. Plasma antioxidants and cognitive performance in middled age and oldere adults: results of the Austrian stroke prevention study. J Am Geriat Soc 1998; 46: 1407-10.
65. Jama WJ, Launer LJ, Witteman JMC, et al. Dietary antioxidants and cognitive function in a population-based sample of older persons: the Rotterdam study. Am J Epidem 1996; 144: 275-80.
66. Masaki KH, White LR, Petrovitch H, et al. The influence of prior and concurrent use of aspirin and vitamins on cognitive function scores in elderly Japanese American men. Neurobiol Aging 1994; Suppl 1, 574.
67. Kalmijin S, Feshens EJM, Launer LJ, Krombout D. Polyunsaturated fatty acids, antioxidants and cognitive function in very old men. Am J Epidem 1997; 145: 33-41.
68. Lohr JB, Caligiuri MP. A double blind placebo controlled study of vitamin E treatment of tardive dyskinesia. J Clin Psychiatry 1996; 57: 167-73.
69. Vyth A, Timner JG, Bossyut PMM, et al. Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants. J Neurol Sci 1996; 139 (suppl): 199-203.